Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Enoxaparin × Clear all

Phase

Phase 3 6 Phase 2 6 Phase NA 4 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Recruiting 3 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thromboembolism 1 Gastrointestinal Neoplasms 1

Interventions

Saline Solution 23 Metformin 23 Zoledronic Acid 22 Dexamethasone 20 Cytarabine 19 Cyclophosphamide 19 Bupivacaine 16 Sodium Chloride 15 Propofol 15 Vincristine 14 Morphine 14 Methotrexate 14 Letrozole 14 Fentanyl 13 Dexmedetomidine 13 Imiquimod 12 Doxorubicin 12 Docetaxel 12 Prednisolone 11 Mercaptopurine 11 Bevacizumab 11 Rituximab 10 Oxycodone 10 Everolimus 10 Cisplatin 10 Capecitabine 10 Acetaminophen 10 nilotinib 9 enzalutamide 9 Ropivacaine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02444572 2021-07-29

ENOXACARE

Les Laboratoires des Médicaments Stériles

Phase 4 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡